Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

Restrictions to Be Updated for Some Injection Procedure Codes

Last updated on

Effective October 1, 2022, diagnosis restrictions will be updated for the following injection procedure codes:

  • Ibutilide fumarate (procedure code J1742) will no longer be diagnosis restricted.
  • Melphalan (procedure code J9245) and melphalan (Evomela) (procedure code J9246) will be restricted to diagnosis codes C9000, C9001, and C9002.

For more information, call the TMHP-CSHCN Services Program Contact Center at 800-568-2413.